Regulatory Effect of Gigukjihwangtanggami on Cytokine Production in Patients with Cerebral Infarction

  • Lee, Min-Goo (Department of Internal Medicine, College of Oriental Medicine,Department of 3rd Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Park, Sae-Wook (Department of Internal Medicine, College of Oriental Medicine,Department of 3rd Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Lee, Sun-Woo (Department of Internal Medicine, College of Oriental Medicine,Department of 3rd Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Son, Ji-Woo (Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Kang, Baek-Gyu (Department of Internal Medicine, College of Oriental Medicine,Department of 3rd Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University) ;
  • Park, Sang-Moo (Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Lee, In (Department of Internal Medicine, College of Oriental Medicine, Wonkwang University) ;
  • Moon, Byung-Soon (Department of Internal Medicine, College of Oriental Medicine,Department of 3rd Medicine, Professional Graduate School of Oriental Medicine, Wonkwang University)
  • Published : 2006.08.25

Abstract

The Korean genuine medicine, 'Gigukjihwangtanggami (GJT)' has long been used clinically for hypertension and various cerebrovascular diseases. However, experimental study has been carried out very little. Recently cytokines involved in the regulation of inflammatory reactions and immune responses may play an important role in the pathogenesis of cerebral infarction (CI). The aim of this study is to investigate the effect of GJT on the production of pro-inflammatory cytokines and anti-inflammatory cytokines in peripheral blood mononuclear cells (PBMCS) stimulated with lipopolysaccaride (LPS) from Cl patients. The amount of tumor necrosis $factor-{\alpha}\;(TNF-{\alpha}),\;interleukin-1{\beta}\;(IL-1{\beta})$, IL-6, IL-8, IL-4 and IL-10 in PBMC culture supernatant was significantly increased in the LPS treated cells compared to unstimulated cells. GJT inhibited the production of $TNF-{\alpha},\;IL-1{\beta}$, IL-6 and IL-8 induced by LPS. The maximal inhibition rate of the $TNF-{\alpha},\;IL-1{\beta}$, IL-6 and IL-8 production by pretreatment of GJT (1 mg/ml) was $57.32{\pm}2.5%$ (p.0.05), $42.02{\pm}3.5%$ (p.0.05), $40.02{\pm}2.3%$ (p.0.05) and $48.02{\pm}3.1$, (p.0.05), respectively. In the Other hand, GJT increased the production of IL-4 and IL-10. The maximal increase rate of the IL-4 and IL-10 production by pretreatment of GJT (1 mg/ml) was $42.4{\pm}3.3%$ (p.0.05) End $56.4{\pm}2.9%$ (p.0.05), respectively. Taken together, these results indicate that GJT Ray have regulatory effects on the cytokine production and suggest that GJT might use clinically for the treatment of CI.

Keywords

References

  1. Chinese Oriental Medicine encyclopedia. Beijing, People's Medical Publishing House, p 109, 1981
  2. Jeon Eul. Soayakjeungjikgyeol. Jiangsu, Jiangsu scientific & Technical Publishers, p 109, 1981
  3. Jang HoHyeon. Study on the Antioxidative Effects and its Mechanism of Gigukjihwang-tang in Neuronal Cells. Wonkwang Univ. 2004
  4. An Il Hoe. Effect of hte Water Extract of Gi Kook Jee Hwang Tang on the Blood Pressrue of Rabbits. Wonkwang Univ., 1988
  5. Stoll, G., Jander, S., Schroeter, M. Inflammation and glial responses in ischemic brain lesions. Progress in Neurobiology 56, 149-171, 1988
  6. Ross, R. Atherosclerosis, an inflammatory disease. New England Journal of Medicine, 340, 115-126, 1999 https://doi.org/10.1056/NEJM199901143400207
  7. Woods, A., Brull, D.J., Humphries, S.E., Montgomery, H.E. Genetics of inflammation and risk of coronary artery disease, the central role of interleukin-6. European Heart Journal, 21, 1574-1583, 2000 https://doi.org/10.1053/euhj.1999.2207
  8. Shohami, E., Ginis, I., Allenbeck, J.M. Dual role of tumor necrosis factor alpha in brain injury. Cytokine & Growth Factor Reviews, 10, 119-130, 1999 https://doi.org/10.1016/S1359-6101(99)00008-8
  9. Kawamata, T., Dietrich, W.D., Schallert, T., Gotts, J.E., Cocke, R.R., Benowitz, L.I., Finklestein, S.P. Intracisternal basic fibroblast growth factor enhances functional recovery and up-regulates the expression of a molecular marker of neuronal sprouting following focal cerebral infarction. Proceedings of The National Academy of Sciences of the United States of America, 94, 8179-8184, 1997
  10. Touzani, O., Boutin, H., Chuquet, J., Rothwel,l N. Potential mechanisms of interleukin-1 involvement in cerebral ischaemia. J Neuroimmunol, 100, 203-215, 1999 https://doi.org/10.1016/S0165-5728(99)00202-7
  11. Rothwell, N.J., Luheshi, G.N. Interleukin 1 in the brain, biology, pathology and therapeutic target. Trends Neurosci, 23, 618-625, 2000 https://doi.org/10.1016/S0166-2236(00)01661-1
  12. Wang, X., Yue, T.L., Barone, F.C., White, R.F., Gagnon, R.C., Feuerstein, G.Z. Concomitant cortical expression of TNF-alpha and IL-1 beta mRNAs follows early response gene expression in transient focal ischemia. Mol Chem Neuropathol, 23, 103-114, 1994 https://doi.org/10.1007/BF02815404
  13. Hillhouse, EW, Kida, S., Iannotti, F. Middle cerebral artery occlusion in the rat causes a biphasic production of immunoreactive interleukin-1beta in the cerebral cortex. Neurosci Lett, 249, 177-179, 1998 https://doi.org/10.1016/S0304-3940(98)00392-9
  14. Zhang, Z., Chopp, M., Goussev, A., Powers, C. Cerebral vessels express interleukin 1beta after focal cerebral ischemia. Brain Res, 784, 210-217, 1998 https://doi.org/10.1016/S0006-8993(97)01317-6
  15. Benveniste, E.N. Inflammatory cytokines within the central nervous system, Sources, function, and mechanism of action. American Journal of Physiology-Cell Physiology, 263, 116-122, 1992 https://doi.org/10.1152/ajprenal.1992.263.1.F116
  16. Vila, N., Reverter, J.C., Yague, J., Chamorro, A. Interaction between interleukin-6 and the natural anticoagulant system in acute stroke. Journal of Interferon and Cytokine Research, 20, 325-329, 2000 https://doi.org/10.1089/107999000312478
  17. Matsumoto, T., Ikeda, K., Mukaida, N., Harada, A., Matsumoto, Y., Yamashita, J., Matsushima, K. Prevention of cerebral edema and infarct in cerebral reperfusion injury by an antibody to interleukin-8. Laboratory Investigation, 77, 119-125, 1997
  18. Paul, W.E. Interleukin-4, a prototypic immunoregulatory lymphokine. Blood, 77, 1859-1870, 1991
  19. Mitchell, L.C., Davis, L.S., Lipsky, P.E. Promotion of human T lymphocyte proliferation by IL-4. Journal of Immunology, 142, 1548-1557, 1989
  20. Sempowski, G.D., Beckmann, M.P., Derdak, S., Phipps, R.P. Subsets of murine lung fibroblasts express membrane- bound and soluble IL-4 receptors. Role of IL-4 in enhancing fibroblast proliferation and collagen synthesis. Journal of Immunology, 152, 3606-3614, 1994
  21. Geng, Y., Gulbins, E., Altman, A., Lotz, M. Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proceedings of the National Academy of Sciences of the United States of Ameica, 91, 8602-8606, 1994
  22. Howard, M., O'Garra, A. Biological properties of interleukin 10. Immunology Today, 13, 198-200, 1992 https://doi.org/10.1016/0167-5699(92)90153-X
  23. Le Moine, O., Louis, H., Demols, A., Desalle, F., Demoor, F., Quertinmont,E., Goldman, M., Deviere, J. Cold liver ischemia-reperfusion injury critically depends on liver T-cells and is improved by donor pretreatment with interleukin 10 in mice. Hepatology, 31, 1266-1274, 2000 https://doi.org/10.1053/jhep.2000.7881
  24. Kim, H.M., An, C.S., Jung, K.Y., Choo, Y.K., Park, J.K., Nam, S.Y. Rehmannia glutinosa inhibits tumour necrosis factor-alpha and interleukin-1 secretion from mouse astrocytes. Pharmacol Res, 40, 171-176, 1999 https://doi.org/10.1006/phrs.1999.0504
  25. Kim, M.J., Kim, H.N., Kang, K.S., Baek, N.I., Kim, D.K., Kim, Y.S., Kim, S.H., Jean, B.H. Methanol extract of Dioscoreae Rhizoma inhibits pro-inflammatory cytokines and mediators in the synoviocytes of rheumatoid arthritis. Int Immunopharmacol, 4, 1489-1497, 2004 https://doi.org/10.1016/j.intimp.2004.07.001
  26. Yasukawa, K., Kaminaga, T., Kitanaka, S., Tai, T., Nunoura, Y., Natori, S., Takido, M. 3 beta-p- hydroxybenzoyldehydrotumulosic acid from Poria cocos, and its anti-inflammatory effect. Phytochemistry, 48, 1357-1360, 1998 https://doi.org/10.1016/S0031-9422(97)01063-7
  27. Jia, W., Gao, W.Y., Cui, N.Q., Xiao, P.G. Anti-inflammatory effects of an herbal medicine(Xuan-Ju agent) on carrageenan- and adjuvant-induced paw edema in rats. J Ethnopharmacol. 89139-89141, 2003
  28. Tomimoto, H., Akiguchi, I., Wakita, H., Kinoshita, A., Ikemoto, A., Nakamura, S., Kimura, J. Glial expression of cytokines in the brains of cerebrovascular disease patients. Acta Neuropathologica, 92, 281-287, 1996 https://doi.org/10.1007/s004010050519
  29. Ferrarese, C., Mascarucci, P., Zoia, C., Cavarretta, R., Frigo, M., Begni, B. Increased cytokine release from peripheral blood cells after acute stroke. Journal of Cerebral Blood Flow and Metabolism, 6, 1004-1009, 1999
  30. Chertov, O., Michiel, D.F., Xu, L.,Wang, J.M., Tani, K., Murphy, W.J., Longo, D.L., Taub, D.D., Oppenheim, J.J. Indentification of defensin-1, defensin-2, and CAP37/Azurocidin as T-cell chemoattractant proteins released from interleukin-8-stimulated neutrophils. Journal of Biological Chemistry, 271, 2935-2940, 1996 https://doi.org/10.1074/jbc.271.6.2935
  31. Fassbender, K., Rossol, S., Kammer, T.,Daffertshofer, M., Wirth, S., Dollman, M. pro-inflammatory cytokines in serum of patients with acute cerebral ischemia, kinetics of secretion and relation to the extent of brain damage and outcome of disease. Journal of Neuroscience, 19, 135-139, 1994
  32. Taub, D.D., Anver, M., Oppenheim, J.J., Longo, D.L., Murphy, W.J. T lymphocyte recruitment by interleukin-8 (IL-8). Journal of Clinical Investigation, 97, 1931-1941, 1996 https://doi.org/10.1172/JCI118625
  33. Brown, M.A., Hural, J. Functions of IL-4 and control of its expression. Critical Reviews Immunology, 17, 1-32, 1997 https://doi.org/10.1615/CritRevImmunol.v17.i1.10
  34. Gazzinelli, R.T., Oswald, I.P., James, S.L., Sher, A. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages. Journal of Immunology, 148, 1792-1796, 1992
  35. Perini, F., Morra, M., Alecci, M., Galloni, E., Marchi, M., Toso, V. Temporal profile of serum anti-inflammatory and pro-inflammatory interleukins in acute ischemic stroke patients. Neurological Sciences, 22, 289-296, 2001 https://doi.org/10.1007/s10072-001-8170-y